ArticleInternational journal of biological sciences2023

Syntaxin-6 promotes the progression of hepatocellular carcinoma and alters its sensitivity to chemotherapies by activating the USF2/LC3B axis.

Lianer Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.